ZT5-45893-81283

3 vaccinations 6 coded responses 37 check-ins 6 free-text entries 2 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 300 / GA
Registered: 2020-12-22

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Registered dependents

SRW-22111-97603 Child or adolescent in my care · Female · 2022-06-26

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Registered in v-safe
2020-12-22
Dose 1 — Pfizer-BioNTech
2020-12-22
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-06
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-12
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-01-14
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body aches, Nausea · Be unable to do your normal daily activities

Free text: Ipsilateral axillary lymphadenopathy-moderate

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-15
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Fever

Free text: Right-sided, painful axillary lymphadenopathy, moderate

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-04
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-15
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-27
Dose 3 — Pfizer-BioNTech
2021-09-29
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache

Free text: Moderate right-sided lymphadenopathy, same side as vaccination

MedDRA releases: 2024-11 · check-in free text available
2021-09-30
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good · Headache

Free text: Mild right-sided axillary lympadenopathy

MedDRA releases: 2024-11 · check-in free text available
2021-10-01
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-02
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-10-03
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-10-04
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-11
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-10-18
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-10-25
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-11-03
Survey response — day 35, dose 3
MedDRA: Dysuria, Haemorrhage urinary tract, Urinary tract infection — Feeling: Fair · Be unable to do your normal daily activities

Free text: First UTI in several years. Dysuria with blood clots.

MedDRA releases: 2024-11 · check-in free text available
2021-11-08
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-12-27
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-03-28
Survey response — 6 months, dose 3
MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: I have had 3 miscarriages in the since July 2021.

MedDRA releases: 2024-11 · check-in free text available
2022-03-28
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-03-30
Call 1 — Requested Callback
2022-03-30
Callback requested for
03:30PM ET
2022-03-30
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech
3	2021-09-27	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-14	priority 2/3
2022-03-28	Successful 2022-03-30	Participant prefers to complete VAERS report online

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Ipsilateral axillary lymphadenopathy-moderate

2021-01-15

Systemic reaction (other): Right-sided, painful axillary lymphadenopathy, moderate

Release 9 — days 1–6 daily, dose 3

2021-09-29

Systemic reaction (other): Moderate right-sided lymphadenopathy, same side as vaccination

2021-09-30

Systemic reaction (other): Mild right-sided axillary lympadenopathy

Release 10 — day 35, dose 3

2021-11-03

Symptoms: First UTI in several years. Dysuria with blood clots.

Release 11 — 6 months, dose 3

2022-03-28

Symptoms: I have had 3 miscarriages in the since July 2021.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	·	·	✓
SD	Dysuria	·	·	✓
SD	Haemorrhage urinary tract	·	·	✓
SD	Urinary tract infection	·	·	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release